AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: AZD0328
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 64
- Registration Number
- NCT00738959
- Locations
- 🇬🇧
Research Site, London, United Kingdom
To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: AZD1305Drug: Placebo
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT00738322
- Locations
- 🇯🇵
Research Site, Fukuoka, Japan
AZD1386 Japanese Multiple Ascending Dosing Study
Phase 1
Completed
- Conditions
- Chronic Pain
- Interventions
- Drug: AZD1386Drug: Placebo
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2009-09-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 32
- Registration Number
- NCT00736658
- Locations
- 🇯🇵
Research Site, Fukuoka, Japan
An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2011-06-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 259
- Registration Number
- NCT00737009
- Locations
- 🇻🇳
Research Site, Hue, Vietnam
Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers
Phase 1
Terminated
- Conditions
- Healthy Volunteers
- Interventions
- Drug: AZD1704Drug: Placebo
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 16
- Registration Number
- NCT00736788
- Locations
- 🇬🇧
Research Site, London, United Kingdom
A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00736606
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 497
- Registration Number
- NCT00736879
- Locations
- 🇺🇸
Valley Research, Fresno, California, United States
🇺🇸Orange County Research Center, Tustin, California, United States
🇺🇸Endocrine Research Solutions, Inc., Roswell, Georgia, United States
Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199
Phase 2
Completed
- Conditions
- AsthmaAirway Obstruction
- Interventions
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 37
- Registration Number
- NCT00736489
- Locations
- 🇸🇪
Research Site, Lund, Sweden
Faslodex Registry: Fulvestrant in Current Clinical Practice
Completed
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 200
- Registration Number
- NCT00735215
- Locations
- 🇧🇪
Research Site, Wilrijk, Belgium
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00733668
- Locations
- 🇧🇪
Research Site, Sint-Truiden, Belgium
© Copyright 2025. All Rights Reserved by MedPath